The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease

Journal of Crohn's and Colitis

Volumn 9, Issue 2, 2015, Pages 107-124

  van der Woude, C J ^a   Ardizzone, S ^b   Bengtson, M B ^c   Fiorino, G ^d   Fraser, G ^e   Katsanos, K ^f   Kolacek, S ^g   Juillerat, P ^h   Mulders, A G M G J ^a   Pedersen, N ⁱ   Selinger, C ^j   Sebastian, S ^k   Sturm, A ^l   Zelinkova, Z ^m   Magro, F ^n,o   Novacek, Gottfried ^p   Bossuyt, Peter ^p   Cavka, Silvija Cukovic ^p   Mijandrusic Sincic, Brankica ^p   Bortlik, Martin ^p   Douda, Tomas ^p   Brynskov, Jørn ^p   Knudsen, Torben ^p   Manninen, Pia ^p   Carbonnel, Franck ^p   Kucharzik, Torsten ^p   Koutroubakis, Ioannis ^p   Lakatos, Peter ^p   Molnar, Tamas ^p   O'Morain, Colm ^p   Kohn, Anna ^p   Gionchetti, Paolo ^p   Kierkus, Jaroslaw ^p   Zagorowicz, Edyta ^p   Diculescu, Mihai Mircea ^p   Jojic, Njegica ^p   Jorda, Francesc Casellas ^p   Strid, Hans ^p   Celik, Aykut Ferhat ^p   Toruner, Murat ^p   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MILAN   (Italy)

^c VESTFOLD HOSPITAL TRUST   (Norway)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^e TEL AVIV UNIVERSITY   (Israel)

^f UNIVERSITY OF IOANNINA   (Greece)

^g Children's University Hospital Zagreb   (Croatia)

^h UNIVERSITY OF BERN   (Switzerland)

ⁱ GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^j ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^k HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^l Waldfriede Hospital   (Germany)

^m UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

ⁿ UNIVERSITY OF PORTO   (Portugal)

^o HOSPITAL DE SÃO JOÃO   (Portugal)

^p NONE   (Turkey)

more..

Author keywords

Crohn's disease; Inflammatory bowel disease; Lactation; Pregnancy; Reproduction; Ulcerative colitis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CIPROFLOXACIN; CORTICOSTEROID; CYCLOSPORIN A; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; SALAZOSULFAPYRIDINE; TACROLIMUS; THALIDOMIDE;

ABDOMINAL SURGERY; ARTICLE; CESAREAN SECTION; CONSENSUS; CROHN DISEASE; DISEASE ACTIVITY; DISEASE PREDISPOSITION; DRUG SAFETY; ENDOSCOPY; EVIDENCE BASED PRACTICE; FEMALE FERTILITY; HUMAN; INFLAMMATORY BOWEL DISEASE; LACTATION; LOW BIRTH WEIGHT; MALE FERTILITY; NONHUMAN; ORAL CONTRACEPTIVE USE; PATIENT CARE; PATIENT COUNSELING; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PROGENY; RECURRENCE RISK; REPRODUCTION; RISK ASSESSMENT; SEXUAL FUNCTION; ULCERATIVE COLITIS; VENOUS THROMBOEMBOLISM; DISEASE MANAGEMENT; EVIDENCE BASED MEDICINE; FEMALE; FERTILITY; INFLAMMATORY BOWEL DISEASES; PREGNANCY COMPLICATION;

CONSENSUS; DISEASE MANAGEMENT; EVIDENCE-BASED MEDICINE; FEMALE; FERTILITY; HUMANS; INFLAMMATORY BOWEL DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 84953887240     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jju006     Document Type: Article

References (287)

1. van der Woude CJ, Kolacek S, Dotan I, et al., European Crohns Colitis Org E. European evidenced-based consensus on reproduction in inflammatory bowel disease. Journal of Crohns & Colitis 2010;4:493-510
2. Levels of evidence and grades of recommendation. http://www.cebm.net/ levels_of_evidence.asp. Accessed January 2014
3. Baird DD, Narendranathan M, Sandler RS. Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 1990;99:987-94
4. Hudson M, Flett G, Sinclair TS, Brunt PW, Templeton A, Mowat NA. Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstet 1997;58:229-37
5. Mayberry JF, Weterman IT. European survey of fertility and pregnancy in women with Crohn's disease: a case control study by European collaborative group. Gut 1986;27:821-5
6. Mañosa M, Navarro-Llavat M, Marín L, Zabana Y, Cabré E, Domènech E. Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey. Scand J Gastroenterol 2013;48:427-32
7. Selinger CP, Eaden J, Selby W, et al. Inflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views. J Crohns Colitis 2013;7:e206-13
8. Selinger CP, Eaden J, Selby W, et al. Inflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views. J Crohns Colitis 2012;7:e206-13
9. Ørding Olsen K, Juul S, Berndtsson I, Oresland T, Laurberg S. Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterology 2002;122:15-9
10. Senates E, çolak Y, Erdem ED, et al. Serum anti-Müllerian hormone levels are lower in reproductive-age women with Crohn's disease compared to healthy control women. J Crohns Colitis 2013;7:e29-34
11. Fréour T, Miossec C, Bach-Ngohou K, et al. Ovarian reserve in young women of reproductive age with Crohn's disease. Inflamm Bowel Dis 2012;18:1515-22
12. Marri SR, Ahn C, Buchman AL. Voluntary childlessness is increased in women with inflammatory bowel disease. Inflamm Bowel Dis 2007;13:591-9
13. Tavernier N, Fumery M, Peyrin-Biroulet L, Colombel JF, Gower-Rousseau C. Systematic review: fertility in non-surgically treated inflammatory bowel disease. Aliment Pharmacol Ther 2013;38:847-53
14. Levi AJ, Fisher AM, Hughes L, Hendry WF. Male infertility due to sulphasalazine. Lancet 1979;2:276-8
15. Birnie GG, McLeod TI, Watkinson G. Incidence of sulphasalazine-induced male infertility. Gut 1981;22:452-5
16. O'Moráin C, Smethurst P, Doré CJ, Levi AJ. Reversible male infertility due to sulphasalazine: studies in man and rat. Gut 1984;25:1078-84
17. Toth A. Reversible toxic effect of salicylazosulfapyridine on semen quality. Fertil Steril 1979;31:538-40
18. Dejaco C, Mittermaier C, Reinisch W, et al. Azathioprine treatment and male fertility in inflammatory bowel disease. Gastroenterology 2001;121:1048-53
19. Teruel C, López-San Román A, Bermejo F, et al. Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines. Am J Gastroenterol 2010;105:2003-8
20. Sussman A, Leonard JM. Psoriasis, methotrexate, and oligospermia. Arch Dermatol 1980;116:215-7
21. Mahadevan U, Terdiman JP, Aron J, Jacobsohn S, Turek P. Infliximab and semen quality in men with inflammatory bowel disease. Inflamm Bowel Dis 2005;11:395-9
22. Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004;99:2385-92
23. Villiger PM, Caliezi G, Cottin V, Förger F, Senn A, Østensen M. Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis. Ann Rheum Dis 2010;69:1842-4
24. Tiainen J, Matikainen M, Hiltunen KM. Ileal J-pouch anal anastomosis, sexual dysfunction, and fertility. Scand J Gastroenterol 1999;34:185-8
25. Damgaard B, Wettergren A, Kirkegaard P. Social and sexual function following ileal pouch-anal anastomosis. Dis Colon Rectum 1995;38:286-9
26. Johnson E, Carlsen E, Nazir M, Nygaard K. Morbidity and functional outcome after restorative proctocolectomy for ulcerative colitis. Eur J Surg 2001;167:40-5
27. Davies RJ, O'Connor BI, Victor C, MacRae HM, Cohen Z, McLeod RS. A prospective evaluation of sexual function and quality of life after ileal pouch-anal anastomosis. Dis Colon Rectum.2008;51:1032-5
28. Lepistö A, Sarna S, Tiitinen A, Järvinen HJ. Female fertility and childbirth after ileal pouch-anal anastomosis for ulcerative colitis. Br J Surg 2007;94:478-82
29. Remzi FH, Gorgun E, Bast J, et al. Vaginal delivery after ileal pouch-anal anastomosis: a word of caution. Dis Colon Rectum 2005;48:1691-9
30. Johnson P, Richard C, Ravid A, et al. Female infertility after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2004;47:1119-26
31. Olsen KO, Joelsson M, Laurberg S, Oresland T. Fertility after ileal pouch-anal anastomosis in women with ulcerative colitis. Br J Surg 1999;86:493-5
32. Cornish J, Tan E, Teare J, et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 2007;56:830-7
33. Tulchinsky H, Averboukh F, Horowitz N, et al. Restorative proctocolectomy impairs fertility and pregnancy outcomes in women with ulcerative colitis. Colorectal Dis 2013;15:842-7
34. Cornish JA, Tan E, Teare J, et al. The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review. Dis Colon Rectum 2007;50:1128-38
35. Rajaratnam SG, Eglinton TW, Hider P, Fearnhead NS. Impact of ileal pouch-anal anastomosis on female fertility: meta-analysis and systematic review. Int J Colorectal Dis 2011;26:1365-74
36. Waljee A, Waljee J, Morris AM, Higgins PD. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut 2006;55:1575-80
37. Oresland T, Palmblad S, Ellström M, Berndtsson I, Crona N, Hultén L. Gynaecological and sexual function related to anatomical changes in the female pelvis after restorative proctocolectomy. Int J Colorectal Dis 1994;9:77-81
38. Beyer-Berjot L, Maggiori L, Birnbaum D, Lefevre JH, Berdah S, Panis Y. A total laparoscopic approach reduces the infertility rate after ileal pouchanal anastomosis: a 2-center study. Ann Surg 2013;258:275-82
39. Bartels SA, D'Hoore A, Cuesta MA, Bensdorp AJ, Lucas C, Bemelman WA. Significantly increased pregnancy rates after laparoscopic restorative proctocolectomy: a cross-sectional study. Ann Surg 2012;256:1045-8
40. Hull TL, Joyce MR, Geisler DP, Coffey JC. Adhesions after laparoscopic and open ileal pouch-anal anastomosis surgery for ulcerative colitis. Br J Surg 2012;99:270-5
41. Asztély M, Palmblad S, Wikland M, Hultén L. Radiological study of changes in the pelvis in women following proctocolectomy. Int J Colorectal Dis 1991;6:103-7
42. Van Horn C, Barrett P. Pregnancy, delivery, and postpartum experiences of fifty-four women with ostomies. J Wound Ostomy Continence Nurs 1997;24:151-62
43. Pabby V, Shah S, Cheifetz AS, Burakoff R, Friedman S. In vitro fertilization in patients with ulcerative colitis and ileal pouch anal anastomosis. Gastroenterology 2012;142:S68
44. Reddy D, Murphy SJ, Kane SV, Present DH, Kornbluth AA. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes. Am J Gastroenterol 2008;103:1203-9
45. Bortoli A, Saibeni S, Tatarella M, et al. Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case-control study. J Gastroenterol Hepatol 2007;:542-9
46. Fedorkow DM, Persaud D, Nimrod CA. Inflammatory bowel disease: a controlled study of late pregnancy outcome. Am J Obstet Gynecol 1989;160:998-1001
47. Mogadam M, Dobbins WO, Korelitz BI, Ahmed SW. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology 1981;80:72-6
48. Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology 2007;133:1106-12
49. Pedersen N, Bortoli A, Duricova D, et al. The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women. Aliment Pharmacol Ther 2013;38:501-12
50. Castiglione F, Pignata S, Morace F, et al. Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. Ital J Gastroenterol 1996;28:199-204
51. Riis L, Vind I, Politi P, et al. Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am J Gastroenterol 2006;101:1539-45
52. Nwokolo CU, Tan WC, Andrews HA, Allan RN. Surgical resections in parous patients with distal ileal and colonic Crohn's disease. Gut 1994;35:220-3
53. Agret F, Cosnes J, Hassani Z, et al. Impact of pregnancy on the clinical activity of Crohn's disease. Aliment Pharmacol Ther 2005;21:509-13
54. Ananthakrishnan AN, Zadvornova Y, Naik AS, Issa M, Perera LP. Impact of pregnancy on health-related quality of life of patients with inflammatory bowel disease. J Dig Dis 2012;13:472-7
55. Piccinni MP, Scaletti C, Maggi E, Romagnani S. Role of hormone-controlled Th1-and Th2-type cytokines in successful pregnancy. J Neuroimmunol 2000;109:30-3
56. Alstead EM. Inflammatory bowel disease in pregnancy. Postgrad Med J 2002;78:23-6
57. Ilnyckyji A, Blanchard JF, Rawsthorne P, Bernstein CN. Perianal Crohn's disease and pregnancy: role of the mode of delivery. Am J Gastroenterol 1999;94:3274-8
58. Brandt LJ, Estabrook SG, Reinus JF. Results of a survey to evaluate whether vaginal delivery and episiotomy lead to perineal involvement in women with Crohn's disease. Am J Gastroenterol 1995;90:1918-22
59. Norton C, Dibley LB, Bassett P. Faecal incontinence in inflammatory bowel disease: associations and effect on quality of life. J Crohns Colitis 2012;7:e302-11
60. Ong JP, Edwards GJ, Allison MC. Mode of delivery and risk of fecal incontinence in women with or without inflammatory bowel disease: questionnaire survey. Inflamm Bowel Dis 2007;13:1391-4
61. Smink M, Lotgering FK, Albers L, de Jong DJ. Effect of childbirth on the course of Crohn's disease; results from a retrospective cohort study in the Netherlands. BMC Gastroenterol 2011;11:6
62. Hatch Q, Champagne BJ, Maykel JA, et al. Crohn's disease and pregnancy: the impact of perianal disease on delivery methods and complications. Dis Colon Rectum 2014;57:174-8
63. Hahnloser D, Pemberton JH, Wolff BG, et al. Pregnancy and delivery before and after ileal pouch-anal anastomosis for inflammatory bowel disease: immediate and long-term consequences and outcomes. Dis Colon Rectum. 2004;47:1127-35
64. Ramalingam T, Box B, Mortensen NM. Pregnancy delivery and pouch function after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2003;46:1292
65. Polle SW, Vlug MS, Slors JF, et al. Effect of vaginal delivery on long-term pouch function. Br J Surg 2006;93:1394-401
66. Cornish J, Wooding K, Tan E, Nicholls RJ, Clark SK, Tekkis PP. Study of sexual, urinary, and fecal function in females following restorative proctocolectomy. Inflamm Bowel Dis 2012;18:1601-7
67. Nicholl MC, Thompson JM, Cocks PS. Stomas and pregnancy. Aust N Z J Obstet Gynaecol 1993;33:322-4
68. Lepistö A, Sarna S, Tiitinen A, Järvinen HJ. Female fertility and childbirth after ileal pouch-anal anastomosis for ulcerative colitis. Br J Surg 2007;94:478-82
69. Ravid A, Richard CS, Spencer LM, et al. Pregnancy, delivery, and pouch function after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2002;45:1283-8
70. Moffatt DC, Ilnyckyj A, Bernstein CN. A population-based study of breastfeeding in inflammatory bowel disease: initiation, duration, and effect on disease in the postpartum period. Am J Gastroenterol 2009;104:2517-23
71. Scott HJ, McLeod RS, Blair J, O'Connor B, Cohen Z. Ileal pouch-anal anastomosis: pregnancy, delivery and pouch function. Int J Colorectal Dis 1996;11:84-7
72. Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-17
73. Hutfless S, Li D-K, Heyman MB, Bayless TM, Abramson O, Herrinton LJ. Prenatal and perinatal characteristics associated with pediatric-onset inflammatory bowel disease. Dig Dis Sci 2012;57:2149-56
74. Dotan I, Alper A, Rachmilewitz D, et al. Maternal inflammatory bowel disease has short and long-term effects on the health of their offspring: a multicenter study in Israel. J Crohns Colitis 2013;7:542-50
75. Orholm M, Munkholm P, Langholz E, Nielsen OH, Sorensen TIA, Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med 1991;324:84-8
76. Peeters M, Nevens H, Baert F, et al. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 1996;111:597-603
77. Mahadevan U. Fertility and pregnancy in the patient with inflammatory bowel disease. Gut 2006;55:1198-206
78. Orholm M, Fonager K, Sorensen HT. Risk of ulcerative colitis and Crohn's disease among offspring of patients with chronic inflammatory bowel disease. Am J Gastroenterol 1999;94:3236-8
79. Bennett RA, Rubin PH, Present DH. Frequency of inflammatory boweldisease in offspring of couples both presenting with inflammatory boweldisease. Gastroenterology 1991;100:1638-43
80. Laharie D, Debeugny S, Peeters M, et al. Inflammatory bowel disease in spouses and their offspring. Gastroenterology 2001;120:816-9
81. Shivananda S, LennardJones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut 1996;39:690-7
82. Akolkar PN, GulwaniAkolkar B, Heresbach D, et al. Differences in risk of Crohn's disease in offspring of mothers and fathers with inflammatory bowel disease. Am J Gastroenterol 1997;92:2241-4
83. Zelinkova Z, Stokkers PC, van der Linde K, Kuipers EJ, Peppelenbosch MP, van der Woude CPJ. Maternal imprinting and female predominance in familial Crohn's disease. J Crohns Colitis 2012;6:771-6
84. Bengtson M-B, Solberg IC, Aamodt G, et al. Relationships between inflammatory bowel disease and perinatal factors: both maternal and paternal disease are related to preterm birth of offspring. Inflamm Bowel Dis 2010;16:847-55
85. Lin H-C, Chiu C-CJ, Chen S-F, Lou H-Y, Chiu W-T, Chen Y-H. Ulcerative colitis and pregnancy outcomes in an Asian population. Am J Gastroenterol 2010;105:387-94
86. Mahadevan U, Sandborn WJ, Li D-K, Hakimian S, Kane S, Corley DA. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology 2007;133:1106-12
87. Oron G, Yogev Y, Shkolnik S, et al. Inflammatory bowel disease: risk factors for adverse pregnancy outcome and the impact of maternal weight gain. J Matern Fetal Neonatal Med 2012;25:2256-60
88. Naganunma M, Kunisaki R, Yoshimura N, et al. Conception and pregnancy outcome in women with inflammatory bowel disease: a multicentre study from Japan. J Crohns Colitis 2011;5:317-23
89. Stephansson O, Larsson H, Pedersen L, et al. Crohn's disease is a risk factor for preterm birth. Clin Gastroenterol Hepatol 2010;8:509-15
90. Stephansson O, Larsson H, Pedersen L, et al. Congenital abnormalities and other birth outcomes in children born to women with ulcerative colitis in Denmark and Sweden. Inflamm Bowel Dis 2011;17:795-801
91. Bush MC, Patel S, Lapinski RH, Stone JL. Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med 2004;15:237-41
92. Molnar T, Farkas K, Nagy F, et al. Pregnancy outcome in patients with inflammatory bowel disease according to the activity of the disease and the medical treatment: a case-control study. Scand J Gastroenterol 2010;45:1302-6
93. Nguyen GC, Boudreau H, Harris ML, Maxwell CV. Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol 2009;7:329-34
94. Raatikainen K, Mustonen J, Pajala MO, Heikkinen M, Heinonen S. The effects of pre-and post-pregnancy inflammatory bowel disease diagnosis on birth outcomes. Aliment Pharmacol Ther 2011;33:333-9
95. Bortoli A, Pedersen N, Duricova D, et al. Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-Epi-Com study, 2003-2006. Aliment Pharmacol Ther 2011;34:724-34
96. Norgard B, Puho E, Pedersen L, Czeizel AE, Sorensen HT. Risk of congenital abnormalities in children born to women with ulcerative colitis: a population-based, case-control study. Am J Gastroenterol 2003;98:2006-10
97. Dominitz JA, Young JCC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol 2002;97:641-8
98. Akbari M, Shah S, Velayos FS, Mahadevan U, Cheifetz AS. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm Bowel Dis 2013;19:15-22
99. Cleary BJ, Kallen B. Early pregnancy azathioprine use and pregnancy outcomes. Birth Defects Research Part A. Clin Mol Teratol 2009;85:647-54
100. Goldstein LH, Dolinsky G, Greenberg R, et al. Pregnancy outcome of women exposed to azathioprine during pregnancy. Birth Defects Research Part A. Clin Mol Teratol 2007;79:696-701
101. Norgard B, Hundborg HH, Jacobsen BA, Nielsen GL, Fonager K. Disease activity in pregnant women with Crohn's disease and birth outcomes: a regional Danish cohort study. Am J Gastroenterol 2007;102:1947-54
102. Casanova MJ, Chaparro M, Domenech E, et al. Safety of thiopurines and anti-TNF-alpha drugs during pregnancy in patients with inflammatory bowel disease. Am J Gastroenterol 2013;108:433-40
103. Coelho J, Beaugerie L, Colombel JF. Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study. Gut 2011;60:198-203
104. Jharap B, de Boer NKH, Stokkers P, et al. Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease. Gut 2014;63:451-7
105. Nielsen OH, Maxwell C, Hendel J. IBD medications during pregnancy and lactation. Nat Rev Gastroenterol Hepatol 2014;11:116-27
106. Angelberger S, Reinisch W, Messerschmidt A, et al. Long-term followup of babies exposed to azathioprine in utero and via breastfeeding. J Crohns Colitis 2011;5:95-100
107. de Meij TGJ, Jharap B, Kneepkens CMF, van Bodegraven AA, de Boer NKH, Dutch Initiative Crohn C. Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease. Aliment Pharmacol Ther 2013;38:38-43
108. Ng SW, Mahadevan U. Management of inflammatory bowel disease in pregnancy. Exp Rev Clin Immunol 2013;9:161-74
109. Norgard BM. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy. Dan Med Bull 2011;58
110. Ban L, Tata LJ, Fiaschi L, Card T. Limited risks of major congenital anomalies in children of mothers with ibd and effects of medications. Gastroenterology 2014;146:76-84
111. Shim L, Eslick GD, Simring AA, Murray H, Weltman MD. The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD). J Crohns Colitis 2011;5:234-8
112. Schnitzler F, Fidder H, Ferrante M, et al. Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy. Inflamm Bowel Dis 2011;17:1846-54
113. Bortlik M, Machkova N, Duricova D, et al. Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-alpha therapy during pregnancy: three-center study. Scand J Gastroenterol 2013;48:951-8
114. Nielsen OH, Loftus EV Jr, Jess T. Safety of TNF-alpha inhibitors during IBD pregnancy: a systematic review. BMC Med 2013;11:174
115. Mahadevan U. Pregnancy and inflammatory bowel disease (reprinted from Gastroenterol Clin North Am 2013;38:1097-108). Med Clin North Am 2010;94:53-73
116. Mahadevan U, Kane SV, Church JA, Vasiliauskas EA, Sandborn WJ, Dubinsky MC. The effect of maternal peripartum infliximab use on neonatal immune response. Gastroenterology 2008;134:A69-A
117. Kaine JL, Kivitz AJ, Birbara C, Luo AY. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J Rheumatol 2007;34:272-9
118. Cheent K, Nolan J, Shariq S, Kiho L, Pal A, Arnold J. Case Report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. J Crohns Colitis 2010;4:603-5
119. Djokanovic N, Klieger-Grossmann C, Pupco A, Koren G. Safety of infliximab use during pregnancy. Reprod Toxicol 2011;32:93-7
120. Kane SV, Acquah LA. Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am J Gastroenterol 2009;104:228-33
121. Mahadevan U, Wolf DC, Dubinsky M, et al. Placental transfer of antitumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2013;11:286-92
122. Zelinkova Z, de Haar C, de Ridder L, et al. High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy. Aliment Pharmacol Ther 2011;33:1053-8
123. Zelinkova Z, van der Ent C, Bruin KF, et al. Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure. Clin Gastroenterol Hepatol 2013;11:318-21
124. Hanan IM. Inflammatory bowel disease in the pregnant woman. Compr Ther 1998;24:409-14
125. Nielsen OH, Andreasson B, Bondesen S, Jarnum S. Pregnancy in ulcerative-colitis. Scand J Gastroenterol 1983;18:735-42
126. Nielsen OH, Andreasson B, Bondesen S, Jacobsen O, Jarnum S. Pregnancy in Crohns-disease. Scand J Gastroenterol 1984;19:724-32
127. Miller JP. Inflammatory bowel-disease in pregnancy a review. J R Soc Med 1986;79:221-5
128. Khosla R, Willoughby CP, Jewell DP. Crohn's-disease and pregnancy. Gut 1984;25:52-6
129. Willoughby CP, Truelove SC. Ulcerative-colitis and pregnancy. Gut 1980;21:469-74
130. Woolfson K, Cohen Z, McLeod RS. Crohns-disease and pregnancy. Dis Colon Rectum 1990;33:869-73
131. Beniada A, Benoist G, Maurel J, Dreyfus M. Inflammatory bowel disease and pregnancy: report of 76 cases and review of the literature. J Gynecol Obstet Biol Reprod (Paris) 2005;34:581-8
132. Baiocco PJ, Korelitz BI. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. J Clin Gastroenterol 1984;6:211-6
133. Korelitz BI. Inflammatory bowel disease and pregnancy. Gastroenterol Clin North Am 1998;27:213-24
134. Broms G, Granath F, Linder M, Stephansson O, Elmberg M, Kieler H. Complications from inflammatory bowel disease during pregnancy and delivery. Clin Gastroenterol Hepatol 2012;10:1246-52
135. Norgard B, Fonager K, Pedersen L, Jacobsen BA, Sorensen HT. Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study. Gut 2003;52:243-7
136. Norgard B, Pedersen L, Christensen LA, Sorensen HT. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol 2007;102:1406-13
137. Mahadevan U, Corley D. Aminosalicylate (ASA) use during pregnancy is not associated with increased adverse events or congenital malformations (CM) in women with inflammatory bowel disease (IBD). Gastroenterol 2006;130:A40
138. Norgard B, Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT. Population-based case control study of the safety of sulfasalazine use during pregnancy. Aliment Pharmacol Ther 2001;15:483-6
139. Cornish J, Tan E, Teare J, et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 2007;56:830-7
140. Rahimi R, Nikfar S, Rezaie A, Abdollahi M. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: A meta-analysis. Reprod Toxicol 2008;25:271-5
141. Hernandez-Diaz S, Su Y-C, Mitchell AA, Kelley KE, Calafat AM, Hauser R. Medications as a potential source of exposure to phthalates among women of childbearing age. Reprod Toxicol 2013;37:1-5
142. Singh A, Martin CF, Kane SV, et al. Is asacol use associated with congenital anomalies? Results from a nationwide prospective pregnancy registry. Gastroenterology 2013;144:S379-S
143. Jurewicz J, Hanke W. Exposure to phtalates: reproductive outcome and children health. A review of epidemiological studies. Int J Occup Med Environ Health 2011;24:115-41
144. Reddy D, Murphy SJ, Kane SV, Present DH, Kornbluth AA. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes. Am J Gastroenterol 2008;103:1203-9
145. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000;62:385-92
146. Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol 2007;197:683-4
147. Gur C, Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol 2004;18:93-101
148. Hviid A, Molgaard-Nielsen D. Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ 2011;183:796-804
149. Homar V, Grosek S, Battelino T. High-dose methylprednisolone in a pregnant woman with Crohn's disease and adrenal suppression in her newborn. Neonatology 2008;94:306-9
150. Beaulieu DB, Ananthakrishnan AN, Issa M, et al. Budesonide induction and maintenance therapy for Crohn's disease during pregnancy. Inflamm Bowel Dis 2009;15:25-8
151. Martel MJ, Rey E, Beauchesne MF, et al. Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control study. BMJ 2005;330:230-3
152. Pang SY, Clark AT, Freeman LC, et al. Maternal side-effects of prenatal dexamethasone therapy for fetal congenital adrenal-hyperplasia. J Clin Endocrinol Metab 1992;75:249-53
153. de Boer NKH, Jarbandhan SVA, de Graaf P, Mulder CJJ, van Elurg RM, van Bodegraven AA. Azathioprine use during pregnancy: Unexpected intrauterine exposure to metabolites. Am J Gastroenterol 2006;101:1390-2
154. Cassina M, Fabris L, Okolicsanyi L, et al. Therapy of inflammatory bowel diseases in pregnancy and lactation. Exp Opin Drug Saf 2009;8:695-707
155. Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present DH. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 2003;124:9-17
156. Langagergaard V, Pedersen L, Gislum M, Norgard B, Sorensen HT. Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: a Danish nationwide cohort study. Aliment Pharmacol Ther 2007;25:73-81
157. Hutson JR, Matlow JN, Moretti ME, Koren G. The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy. J Obstet Gynaecol 2013;33:1-8
158. De Boer NKH, Van Elburg RM, Wilhelm AJ, et al. 6-Thioguanine for Crohn's disease during pregnancy: Thiopurine metabolite measurements in both mother and child. Scand J Gastroenterol. 2005;40:1374-7
159. Bar-Oz B, Hackman R, Einarson T, Koren G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 2001;71:1051-5
160. Jain AB, Reyes J, Marcos A, et al. Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation 2003;76:827-32
161. Branche J, Cortot A, Bourreille A, et al. Cyclosporine treatment of steroid-refractory ulcerative colitis during pregnancy. Inflamm Bowel Dis 2009;15:1044-8
162. Baumgart DC, Sturm A, Wiedenmann B, Dignass AU. Uneventful pregnancy and neonatal outcome with tacrolimus in refractory ulcerative colitis. Gut 2005;54:1822-3
163. Dara P, Slater LM, Armentrout SA. Successful pregnancy during chemotherapy for acute leukemia. Cancer 1981;47:845-6
164. Kozlowski RD, Steinbrunner JV, Mackenzie AH, Clough JD, Wilke WS, Segal AM. Outcome of 1st-trimester exposure to low-dose methotrexate in 8 patients with rheumatic disease. Am J Med 1990;88:589-92
165. Smithells RW, Newman CGH. Recognition of thalidomide defects. J Med Genet 1992;29:716-23
166. Vasiliauskas EA, Church JA, Silverman N, Barry M, Targan SR, Dubinsky MC. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol 2006;4:1255-8
167. Mahadevan U, Terdiman JP, Church J, Vasiliauskas E, Gitis A, Dubinsky MC. Infliximab levels in infants born to women with inflammatory bowel disease. Gastroenterology 2007;132:A144-A
168. Mahadevan U, Martin CF, Sandler RS, et al. PIANO: a 1000 patient prospective registry of pregnancy outcomes in women with ibd exposed to immunomodulators and biologic therapy. Gastroenterology 2012;142:S149-S
169. Winger EE, Reed JL. Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol 2008;60:8-16
170. Nesbitt AM, Brown DT, Stephens S, Foulkes R. Placental transfer and accumulation in milk of the anti-TNF antibody TN3 in rats: Immunoglobulin G1 versus PEGylated Fab'. Am J Gastroenterol 2006;101:S438-S
171. Mahadevan U, Abreu MT. Certolizumab use in pregnancy: low levels detected in cord blood. Gastroenterology 2009;136:A146-A
172. Aratari A, Margagnoni G, Koch M, Papi C. Intentional infliximab use during pregnancy for severe steroid-refractory ulcerative colitis. J Crohns Colitis 2011;5:262
173. Piper JM, Mitchel EF, Ray WA. Prenatal use of metronidazole and birthdefects-no association. Obstet Gynecol 1993;82:348-52
174. Schwebke JR. Metronozadole-Utilization in the obstetric and gynecologic patient. Sex Transm Dis 1995;22:370-6
175. Koss CA, Baras DC, Lane SD, et al. Investigation of metronidazole use during pregnancy and adverse birth outcomes. Antimicrob Agents Chemother 2012;56:4800-5
176. Berkovitch M, Pastuszak A, Gazarian M, Lewis M, Koren G. Safety of the new quinolones in pregnancy. Obstet Gynecol 1994;84:535-8
177. Linseman DA, Hampton LA, Branstetter DG. Quinolone-induced arthropathy in the neonatal mouse-morphological analysis of articular lesions produced by pipedemic acid and ciprofloxacin. Fundam Appl Toxicol 1995;28:59-64
178. Hay G, Clausen T, Whitelaw A, et al. Maternal folate and cobalamin status predicts vitamin status in newborns and 6-month-old infants. J Nutr 2010;140:557-64
179. Czeizel AE, Dudas I, Metneki J. Pregnancy outcomes in a randomized controlled trial of periconcenptional multivitamin supplementation-final report. Arch Gynecol Obstet 1994;255:131-9
180. Czeizel AE, Toth M, Rockenbauer M. Population-based case control study of folic acid supplementation during pregnancy. Teratology 1996;53:345-51
181. Morris JK, Wald NJ. Prevalence of neural tube defect pregnancies in England and Wales from 1964 to 2004. J Med Screen 2007;14:55-9
182. Blencowe H, Cousens S, Modell B, Lawn J. Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol 2010:39(Suppl 1):110-21
183. Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006;24:1507-23
184. Kovacs CS. Vitamin D in pregnancy and lactation: maternal, fetal, and neonatal outcomes from human and animal studies. Am J Clin Nutr 2008;88:520S-8S
185. World Health Organization. Compilation of WHO Recommendations on Maternal, Newborn, Child and Adolescent Health. Geneva: World Health Organization; 2013
186. Hill J, Clark A, Scott NA. Surgical treatment of acute manifestations of Crohn's disease during pregnancy. J R Soc Med 1997;90:64-6
187. Kane S. Inflammatory bowel disease in pregnancy. Gastroenterol Clin North Am 2003;32:323-40
188. Visser BC, Glasgow RE, Mulvihill KK, Mulvihill SJ. Safety and timing of nonobstetric abdominal surgery in pregnancy. Dig Surg 2001;18:409-17
189. Julsgaard M, Norgaard M, Hvas CL, Buck D, Christensen LA. Selfreported adherence to medical treatment prior to and during pregnancy among women with ulcerative colitis. Inflammat Bowel Dis 2011;17:1573-80
190. Nielsen MJ, Norgaard M, Holland-Fisher P, Christensen LA. Selfreported antenatal adherence to medical treatment among pregnant women with Crohn's disease. Aliment Pharmacol Ther 2010;32:49-58
191. Mountifield R, Bampton P, Prosser R, Muller K, Andrews JM. Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Inflamm Bowel Dis 2009;15:720-5
192. Mountifield RE, Prosser R, Bampton P, Muller K, Andrews JM. Pregnancy and IBD treatment: this challenging interplay from a patients' perspective. J Crohns Colitis 2010;4:176-82
193. Vantrigt AM, Waardenburg CM, Haaijer-Ruskamp FM, Dejongvandenberg LTW. Questions about drugs-how do pregnant women solve them. Pharm World Sci 1994;16:254-9
194. Mountifield R, Andrews J, Bampton P. It is worth the effort: patient knowledge of reproductive aspects of inflammatory bowel disease improves dramatically after a single group education session. J Crohns Colitis 2014;S1873-9946:452-2
195. Moshkovska T, Stone MA, Smith RM, Bankart J, Baker R, Mayberry JF. Impact of a tailored patient preference intervention in adherence to 5-aminosalicylic acid medication in ulcerative colitis: results from an exploratory randomized controlled trial. Inflamm Bowel Dis 2011;17:1874-81
196. Bergstrand O, Hellers G. Breast-feeding during infancy in patients who later develop Crohn's disease. Scand J Gastroenterol 1983;18:903-6
197. Manosa M, Navarro-Llavat M, Marin L, Zabana Y, Cabre E, Domenech E. Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey. Scand J Gastroenterol 2013;48:427-32
198. Barclay AR, Russell RK, Wilson ML, Gilmour WH, Satsangi J, Wilson DC. Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease. J Pediatr 2009;155:421-6
199. Eglinton TW, Roberts R, Pearson J, et al. Clinical and genetic risk factors for perianal Crohn's disease in a population-based cohort. Am J Gastroenterol 2012;107:589-96
200. Mogadam M, Korelitz BI, Ahmed SW, Dobbins WO III, Baiocco PJ. The course of inflammatory bowel disease during pregnancy and postpartum. Am J Gastroenterol 1981;75:265-9
201. Hansen TS, Jess T, Vind I, et al. Environmental factors in inflammatory bowel disease: a case-control study based on a Danish inception cohort. J Crohns Colitis 2011;5:577-84
202. Kane S, Lemieux N. The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am J Gastroenterol 2005;100:102-5
203. Penders J, Thijs C, Vink C, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006;118:511-21
204. Saavedra JM, Dattilo AM. Early development of intestinal microbiota: implications for future health. Gastroenterol Clin North Am 2012;41:717-31
205. Rosti L, Braga M, Fulcieri C, Sammarco G, Manenti B, Costa E. Formula milk feeding does not increase the release of the inflammatory marker calprotectin, compared to human milk. La Pediatria Medica e Chirurgica [Medical and Surgical pediatrics] 2011;33:178-81
206. Dorosko SM, Mackenzie T, Connor RI. Fecal calprotectin concentrations are higher in exclusively breastfed infants compared to those who are mixed-fed. Breastfeed Med 2008;3:117-9
207. Esbjorner E, Jarnerot G, Wranne L. Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation. Acta Paediatr Scand 1987;76:137-42
208. Diav-Citrin O, Park YH, Veerasuntharam G, et al. The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology 1998;114:23-8
209. Habal FM, Hui G, Greenberg GR. Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy: safety and clinical course. Gastroenterology 1993;105:1057-60
210. Marteau P, Tennenbaum R, Elefant E, Lemann M, Cosnes J. Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules. Aliment Pharmacol Ther 1998;12:1101-8
211. Heisterberg L, Branebjerg PE. Blood and milk concentrations of metronidazole in mothers and infants. J Perinat Med 1983;11:114-20
212. Gardner DK, Gabbe SG, Harter C. Simultaneous concentrations of ciprofloxacin in breast milk and in serum in mother and breast-fed infant. Clin Pharm 1992;11:352-4
213. Beitins IZ, Bayard F, Ances IG, Kowarski A, Migeon CJ. The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr 1972;81:936-45
214. Ost L, Wettrell G, Bjorkhem I, Rane A. Prednisolone excretion in human milk. J Pediatr 1985;106:1008-11
215. Christensen LA, Dahlerup JF, Nielsen MJ, Fallingborg JF, Schmiegelow K. Azathioprine treatment during lactation. Aliment Pharmacol Ther 2008;28:1209-13
216. Zelinkova Z, De Boer IP, Van Dijke MJ, Kuipers EJ, Van Der Woude CJ. Azathioprine treatment during lactation. Aliment Pharmacol Ther 2009;30:90-1; author reply 1
217. Gardiner SJ, Gearry RB, Roberts RL, Zhang M, Barclay ML, Begg EJ. Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs. Br J Clin Pharmacol 2006;62:453-6
218. Moretti ME, Verjee Z, Ito S, Koren G. Breast-feeding during maternal use of azathioprine. Ann Pharmacother 2006;40:2269-72
219. Schwab M, Klotz U. Pharmacokinetic considerations in the treatment of inflammatory bowel disease. Clin Pharmacokinet 2001;40:723-51
220. Angelberger S, Reinisch W, Messerschmidt A, et al. Long-term followup of babies exposed to azathioprine in utero and via breastfeeding. J Crohns Colitis 2011;5:95-100
221. Gardiner SJ, Begg EJ. Breastfeeding during tacrolimus therapy. Obstet Gynecol 2006;107:453-5
222. Moretti ME, Sgro M, Johnson DW, et al. Cyclosporine excretion into breast milk. Transplantation 2003;75:2144-6
223. Kane S, Ford J, Cohen R, Wagner C. Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery. J Clin Gastroenterol 2009;43:613-6
224. Stengel JZ, Arnold HL. Is infliximab safe to use while breastfeeding? World J Gastroenterol 2008;14:3085-7
225. Ben-Horin S, Yavzori M, Kopylov U, et al. Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease. J Crohns Colitis 2011;5:555-8
226. Ben-Horin S, Yavzori M, Katz L, et al. Adalimumab level in breast milk of a nursing mother. Clin Gastroenterol Hepatol 2010;8:475-6
227. Moody G, Probert CSJ, Srivastava EM, Rhodes J, Mayberry JF. Sexual dysfunction amongst women with Crohn's disease-a hidden problem. Digestion 1992;52:179-83
228. Moody GA, Mayberry JF. Perceived sexual dysfunction amongst patients with inflammatory bowel disease. Digestion 1993;54:256-60
229. Weber AM, Ziegler C, Belinson JL, Mitchinson AR, Widrich T, Fazio V. Gynecologic history of women with inflammatory bowel disease. Obstet Gynecol 1995;86:843-7
230. Fuller-Thomson E, Sulman J. Depression and inflammatory bowel disease: finding from two nationally representative Canadian surveys. Inflamm Bowel Dis 2006;12:697-707
231. Timmer A, Bauer A, Dignass A, Rogler G. Sexual function in persons with inflammatory bowel disease: a survey with matched controls. Clin Gastroenterol Hepatol 2007;5:87-94
232. Muller KR, Prosser R, Bampton P, Mountifield R, Andrews JM. Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease: patient perceptions. Inflamm Bowel Dis 2010;16:657-63
233. Cornish JA, Tan E, Teare J, et al. The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: A systematic review. Dis Colon Rectum 2007;50:1128-38
234. Timmer A, Bauer A, Kemptner D, Fuerst A, Rogler G. Determinants of male sexual function in inflammatory bowel disease: A survey-based crosssectional analysis in 280 men. Inflamm Bowel Dis 2007;13:1236-43
235. Larson DW, Davies MM, Dozois EJ, et al. Sexual function, body image, and quality of life after laparoscopic and open ileal pouch-anal anastomosis. Dis Colon Rectum 2008;51:392-6
236. Hueting WE, Gooszen HG, van Laarhoven C. Sexual function and continence after ileo pouch anal anastomosis: a comparison between a metaanalysis and a questionnaire survey. Int JColorectal Dis 2004;19:215-8
237. Berndtsson I, Oresland T, Hulten L. Sexuality in patients with ulcerative colitis before and after restorative proctocolectomy: a prospective study. Scand J Gastroenterol 2004;39:374-9
238. World Health Organization. Selected Practice Recommendations for Contraceptive Use. Geneva:World Health Organization; 2002
239. Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Gendre JP. Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study. Gut 1999;45:218-22
240. Lashner BA, Kane SV, Hanauer SB. Lack of association between oralcontraceptive use and Crohns-disease-a community-based matched case-control study. Gastroenterology 1989;97:1442-7
241. Cornish JA, Tan E, Simillis C, Clark SK, Teare J, Tekkis PP. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol 2008;103:2394-400
242. Wakefield AJ, Sawyerr AM, Hudson M, Dhillon AP, Pounder RE. SMOKING, THE ORAL-CONTRACEPTIVE PILL, AND CROHNS-DISEASE. Digestive Diseases and Sciences. 1991;36:1147-50
243. Van Vliet HAAM, Bertina RM, Dahm AEA, et al. Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor. J Thromb Haemost 2008;6:346-51
244. Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Koster T, Bertina RM, Vandenbroucke JP. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives. Thromb Haemost 1998;80:382-7
245. Kluft C, Lansink M. Effect of oral contraceptives on haemostasis variables. Thromb Haemost 1997;78:315-26
246. Winkler UH. Blood coagulation and oral contraceptives-A critical review. Contraception 1998;57:203-9
247. Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Female hormones and thrombosis. Arterioscler Thromb Vasc Biol 2002;22:201-10
248. Blickstein D, Blickstein I. Oral contraception and thrombophilia. Curr Opin Obstet Gynecol 2007;19:370-6
249. Curtis KM, Chrisman CE, Peterson HB, Practice WHOPMB. Contraception for women in selected circumstances. Obstet Gynecol 2002;99:1100-12
250. Practice Committee of the American Society for Reproductive M. Hormonal contraception: recent advances and controversies. Fertil Steril 2006;86(5 Suppl 1):S229-35
251. Mohllajee AP, Curtis KM, Martins SL, Peterson HB. Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review. Contraception 2006;73:166-78
252. Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: A population-based cohort study. Thromb Haemost 2001;85:430-4
253. Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 2005;143:697-706
254. Kingdom Tsrotceimdit U. Saving mothers' lives: reviewing maternal deaths to make motherhood safer-2003-2005. 2007. http://www.publichealth. hscni.net/sites/default/files/Saving%20Mothers'%20Lives%20 2003-05%20.pdf. Accessed 2013
255. Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJM. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost 2008;6:632-7
256. Novacek G, Weltermann A, Sobala A, et al. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology 2010;139:779-U114
257. Centre NCG. Venous thromboembolism: reducing the risk: Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. 2010. http://www.nice.org. uk/guidance/cg92/chapter/guidance
258. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005;106:401-7
259. Royal College of Obstetricians and Gynaecologists. Thromboembolic disease in pregnancy and the puerperium: acute management. 2010. http://www.guideline.gov/content.aspx?id=11385&search=Venous+com plication+in+pregnancy+AND%2FOR+the+puerperium+
260. Rahier JF, Magro F, Abreu C, et al. Second European Evidence-Based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2014;8:443-68
261. Brent RL. The effect of embryonic and fetal exposure to x-ray, microwaves, and ultrasound-counseling the pregnant and nonpregnant patient about these risks. Semin Oncol 1989;16:347-68
262. Brent RL. Radiation teratogenesis. Teratology 1980;21:281-98
263. Tamir IL, Bongard FS, Klein SR. Acute appendicitis in the pregnant patient. Am J Surg 1990;160:571-6
264. Kammerer WS. Non-obstetric surgery during pregnancy. Med Clin North Am 1979;63:1157-64
265. Cappell MS. The fetal safety and clinical efficacy of gastrointestinal endoscopy during pregnancy. Gastroenterol Clin North Am 2003;32:123
266. Cappell MS, Colon VJ, Sidhom OA. A study of eight medical centers of the safety and clinical efficacy of esophagogastroduodenoscopy in 83 pregnant females with follow-up of fetal outcome with comparison to control groups. Am J Gastroenterol 1996;91:348-54
267. Quan WL, Chia CK, Yim HB. Safety of endoscopical procedures during pregnancy. Singapore Med J 2006;47:525-8
268. Cappell MS, Colon VJ, Sidhom OA. A study at 10 medical centers of the safety and efficacy of 48 flexible sigmoidoscopies and 8 colonoscopies during pregnancy with follow-up of fetal outcome and with comparison to control groups. Dig Dis Sci 1996;41:2353-61
269. Jamidar PA, Beck GJ, Hoffman BJ, et al. Endoscopic retrograde cholangiopancreatography in pregnancy. Am J Gastroenterol 1995;90:1263-7
270. Tham TCK, Vandervoort J, Wong RCK, et al. Safety of ERCP during pregnancy. Am J Gastroenterol 2003;98:308-11
271. Hani MNB, Bani-Hani KE, Rashdan A, AlWaqfi NR, Heis HA, Al-Manasra A-RA. Safety of endoscopic retrograde cholangiopancreatography during pregnancy. ANZ J Surg 2009;79:23-6
272. Tang S-j, Mayo MJ, Rodriguez-Frias E, et al. Safety and utility of ERCP during pregnancy. Gastrointest Endosc 2009;69:453-61
273. Tang S-J, Rodriguez-Frias E, Singh S, et al. Acute pancreatitis during pregnancy. Clin Gastroenterol Hepatol 2010;8:85-90
274. Samara ET, Stratakis J, Melono JME, Mouzas IA, Perisinakis K, Damilakis J. Therapeutic ERCP and pregnancy: is the radiation risk for the conceptus trivial? Gastrointest Endosc 2009;69:824-31
275. Akcakaya A, Ozkan OV, Okan I, Kocaman O, Sahin M. Endoscopic retrograde cholangiopancreatography during pregnancy without radiation. World J Gastroenterol 2009;15:3649-52
276. Morrison JC, Boyd M, Friedman BI, et al. Effects of renografin-60 on fetal thyroid. Obstet Gynecol 1973;42:99-103
277. Nardulli G, Limongi F, Sue G, Zapata L, Bompart I. Use of polyethylene glycol in the treatment of puerperal constipation. G E N 1995;49:224-6
278. Rimensberger P, Schubiger G, Willi U. Connatal rickets following repeated administration of phosphate enemas in pregnancy-a case-report. Eur J Pediatr 1992;151:54-6
279. Schwethelm B, Margolis LH, Miller C, Smith S. Risk status and pregnancy outcome among medicaid recipients. Am J Prev, Med 1989;5:157-63
280. Carrie LES, Osullivan GM, Seegobin R. Epidural fentanyl in labor. Anaesthesia 1981;36:965-9
281. Fernando R, Bonello E, Gill P, Urquhart J, Reynolds F, Morgan B. Neonatal welfare and placental transfer of fentanyl and bupivacaine during ambulatory combined spinal epidural analgesia for labour. Anaesthesia. 1997;52:517-24
282. Lindemann R. Respiratory muscle rigidity in a preterm infant after use of fentanyl during Caesarean section. Eur J Pediatr 1998;157:1012-3
283. Regan J, Chambers F, Gorman W, MacSullivan R. Neonatal abstinence syndrome due to prolonged administration of fentanyl in pregnancy. BJOG 2000;107:570-2
284. Briggs GG, BPharm F, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. Philadelphia, PA: Lippincott, Williams & Wilkins; 2005
285. Nitsun M, Szokol JW, Saleh HJ, et al. Pharmacokinetics of midazolam, propofol, and fentanyl transfer to human breast milk. Clin Pharmacol Ther 2006;79:549-57
286. Matheson I, Lunde PKM, Bredesen JE. Midazolam and nitrazepam in the maternity ward-milk concentrations and clinical effects. Br J Clin Pharmacol 1990;30:787-93
287. Zelinkova Z, Mensink PB, Dees J, Kuipers EJ, van der Woude CJ. Reproductive wish represents an important factor influencing therapeutic strategy in inflammatory bowel diseases. Scand J Gastroenterol 2010;45:483-9